NDC codes

415464 NDC codes with hospital pricing data in the network.

• NDC 63323-0186-10 — Preservative-free sodium chloride 0.9% injectionAI (700 hospitals, 31,006–32,392 samples)
• NDC 50383-0775-04 — Lidocaine 2% mucosal solutionAI (306 hospitals, 31,358–32,384 samples)
• NDC 00143-9785-10 — Valproate sodium injection, 100 mg/mLAI (668 hospitals, 31,279–32,377 samples)
• NDC 00904-5855-61 — Ibuprofen 800 mg tabletAI (669 hospitals, 31,462–32,371 samples)
• NDC 43066-0016-10 — Cardene IV (nicardipine) premixed infusion bag, 40 mg per 200 mLAI (678 hospitals, 29,130–32,361 samples)
• NDC 47335-0703-49 — Albuterol sulfate nebulizer solution 2.5 mgAI (149 hospitals, 31,225–32,359 samples)
• NDC 50383-0779-33 — Lactulose 10 g per 15 mL oral solutionAI (111 hospitals, 31,342–32,359 samples)
• NDC 69339-0138-19 — CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASHAI (248 hospitals, 31,355–32,354 samples)
• NDC 43066-0997-01 — Norepinephrine 1 mg/mL IV solutionAI (346 hospitals, 31,301–32,354 samples)
• NDC 61314-0645-11 — Neomycin, polymyxin and hydrocortisone ear drops, 10 mL bottleAI (597 hospitals, 31,335–32,352 samples)
• NDC 60505-1003-01 — Ketorolac eye drops (0.5% solution)AI (695 hospitals, 31,176–32,346 samples)
• NDC 00591-3510-54 — Clonidine 0.3 mg/24-hour transdermal patchAI (271 hospitals, 31,145–32,342 samples)
• NDC 70069-0601-01 — Proparacaine eye drops, 0.5%AI (275 hospitals, 31,252–32,341 samples)
• NDC 00904-6370-61 — Amlodipine 5 mg tabletsAI (855 hospitals, 31,470–32,334 samples)
• NDC 50383-0779-15 — Lactulose 10 g per 15 mL oral solutionAI (68 hospitals, 31,397–32,333 samples)
• NDC 70756-0640-25 — Lidocaine 1% injection, preservative-freeAI (137 hospitals, 30,540–32,322 samples)
• NDC 72603-0209-01 — Sodium bicarbonate 8.4% intravenous solutionAI (92 hospitals, 31,199–32,315 samples)
• NDC 00527-1695-01 — Butalbital, acetaminophen and caffeine tabletsAI (371 hospitals, 31,728–32,313 samples)
• NDC 00283-0679-02 — Hurricaine 20% benzocaine mouth sprayAI (613 hospitals, 32,066–32,291 samples)
• NDC 00378-9112-16 — Nitroglycerin 24-hour skin patch, 0.4 mg per hourAI (447 hospitals, 31,301–32,282 samples)
• NDC 60219-1748-02 — Atropine 1% eye dropsAI (628 hospitals, 31,158–32,274 samples)
• NDC 00338-0221-03 — Plasma-Lyte A intravenous fluidAI (222 hospitals, 31,293–32,274 samples)
• NDC 70069-0201-01 — PILOCARPINE 4 % EYE DROPSAI (345 hospitals, 31,247–32,273 samples)
• NDC 00641-6061-25 — Midazolam injection, 5 mg per mLAI (430 hospitals, 29,537–32,264 samples)
• NDC 61314-0643-05 — Tobramycin eye dropsAI (573 hospitals, 31,164–32,262 samples)
• NDC 61314-0641-75 — Neomycin, polymyxin, and hydrocortisone ear dropsAI (809 hospitals, 31,137–32,262 samples)
• NDC 63323-0464-09 — Bupivacaine 0.25% preservative-free injectionAI (76 hospitals, 30,749–32,261 samples)
• NDC 00093-3541-43 — Estradiol 0.1 mg/g vaginal creamAI (413 hospitals, 31,119–32,253 samples)
• NDC 00121-4577-15 — Lactulose oral solution 10 g per 15 mLAI (200 hospitals, 31,084–32,245 samples)
• NDC 16714-0496-01 — Clotrimazole and betamethasone topical creamAI (389 hospitals, 31,119–32,235 samples)
• NDC 63323-0494-01 — Valproate 500 mg/5 mL oral solution vialAI (474 hospitals, 31,063–32,215 samples)
• NDC 76204-0100-01 — Ipratropium bromide 0.02% solutionAI (692 hospitals, 31,230–32,211 samples)
• NDC 72266-0158-01 — Moxifloxacin eye dropsAI (518 hospitals, 31,217–32,207 samples)
• NDC 45802-0014-02 — HYDROCORTISONE 2.5 % TOPICAL OINTMENTAI (238 hospitals, 31,242–32,196 samples)
• NDC 71288-0700-06 — Rocuronium bromide injection, 50 mg/5 mL vialAI (235 hospitals, 31,130–32,192 samples)
• NDC 00409-4903-11 — Lidocaine 2% injection, prefilled syringeAI (277 hospitals, 30,694–32,188 samples)
• NDC 00121-0972-51 — Lidocaine 4% solutionAI (228 hospitals, 31,129–32,182 samples)
• NDC 00143-9396-01 — Cisatracurium injection, 10 mg per 5 mLAI (70 hospitals, 31,129–32,182 samples)
• NDC 71288-0712-05 — CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTIONAI (231 hospitals, 31,129–32,182 samples)
• NDC 00143-9836-01 — PENICILLIN V POTASSIUM 500 MG TABLETAI (134 hospitals, 31,596–32,181 samples)
• NDC 00574-4160-35 — Neomycin, polymyxin and dexamethasone eye ointmentAI (297 hospitals, 31,253–32,180 samples)
• NDC 62332-0582-04 — Lidocaine-prilocaine 2.5% topical creamAI (497 hospitals, 31,059–32,175 samples)
• NDC 47781-0426-47 — Fentanyl 50 mcg per hour skin patchAI (590 hospitals, 31,197–32,169 samples)
• NDC 10019-0553-90 — Scopolamine 1 mg transdermal patchAI (489 hospitals, 31,203–32,166 samples)
• NDC 63323-0519-77 — Heparin in sodium chloride IV solutionAI (244 hospitals, 30,640–32,161 samples)
• NDC 00904-7035-88 — Chlorhexidine 0.12% mouthwashAI (211 hospitals, 31,202–32,156 samples)
• NDC 50419-0325-01 — Gadobutrol contrast injection for imagingAI (254 hospitals, 28,209–32,151 samples)
• NDC 00904-6085-61 — Citalopram 20 mg tabletAI (958 hospitals, 31,264–32,146 samples)
• NDC 00116-2001-05 — CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASHAI (69 hospitals, 31,178–32,132 samples)
• NDC 00781-5690-31 — ezetimibe 10 mg tabletAI (163 hospitals, 31,591–32,131 samples)